Trial Profile
A Randomized Double-blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 19 Jul 2022
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Haloperidol
- Indications Nausea and vomiting
- Focus Therapeutic Use
- Acronyms OHN-1
- 18 Jan 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 23 Mar 2009 New trial record.